{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:34:12Z","timestamp":1761294852781,"version":"3.41.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"DOI":"10.1186\/s40794-025-00254-3","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T22:02:40Z","timestamp":1751320960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression and immunogenicity evaluation of a novel Lentiviral multi- epitope vaccine against Leishmania major in BALB\/c mice"],"prefix":"10.1186","volume":"11","author":[{"given":"Mahsa","family":"Rabienia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Roudbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ghanbariasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolmajid","family":"Ghasemian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbar","family":"Farjadfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Mortazavidehkordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"6","key":"254_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","volume":"23","author":"HJ de Vries","year":"2022","unstructured":"de Vries HJ, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022;23(6):823\u201340.","journal-title":"Am J Clin Dermatol"},{"key":"254_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40794-018-0067-3","volume":"4","author":"AM Montalvo","year":"2018","unstructured":"Montalvo AM, Fraga J, Blanco O, Gonzalez D, Monzote L, Soong L, Capo V. Imported leishmaniasis cases in Cuba (2006\u20132016): what have we learned. Trop Dis Travel Med Vaccines. 2018;4:7.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"254_CR3","unstructured":"https:\/\/www.who.int\/health-topics\/leishmaniasis\/the-global-epidemiology-of-leishmaniasis#tab=tab_1. 2024."},{"issue":"1","key":"254_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40794-022-00171-9","volume":"8","author":"L Monzote","year":"2022","unstructured":"Monzote L, Gonzalez D, Blanco O, Fraga J, Capo V, Herrera A, Montalvo AM. Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement. Trop Dis Travel Med Vaccines. 2022;8(1):15.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"254_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40794-019-0092-x","volume":"5","author":"T Schwartz","year":"2019","unstructured":"Schwartz T, Jensenius M, Blomberg B, Fladeby C, Maeland A, Pettersen FO. Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients. Trop Dis Travel Med Vaccines. 2019;5:16.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"254_CR6","doi-asserted-by":"crossref","unstructured":"Zutshi S, Kumar S, Chauhan P, Bansode Y, Nair A, Roy S, Sarkar A, Saha B: Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments. Vaccines (Basel). 2019;7(4).","DOI":"10.3390\/vaccines7040156"},{"issue":"24","key":"254_CR7","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1016\/j.vaccine.2019.04.068","volume":"37","author":"S Elikaee","year":"2019","unstructured":"Elikaee S, Mohebali M, Rezaei S, Eslami H, Khamesipour A, Keshavarz H, Eshraghian MR. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB\/c mice. Vaccine. 2019;37(24):3221\u20138.","journal-title":"Vaccine"},{"issue":"5","key":"254_CR8","doi-asserted-by":"publisher","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","volume":"11","author":"M Osman","year":"2017","unstructured":"Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di Marco S, Colloca S, Siani L, et al. A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Negl Trop Dis. 2017;11(5):e0005527.","journal-title":"PLoS Negl Trop Dis"},{"issue":"30","key":"254_CR9","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1016\/j.vaccine.2014.04.088","volume":"32","author":"BS Lakshmi","year":"2014","unstructured":"Lakshmi BS, Wang R, Madhubala R. Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis. Vaccine. 2014;32(30):3816\u201322.","journal-title":"Vaccine"},{"issue":"1","key":"254_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40794-021-00147-1","volume":"7","author":"KM Adam","year":"2021","unstructured":"Adam KM. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Trop Dis Travel Med Vaccines. 2021;7(1):22.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"21","key":"254_CR11","doi-asserted-by":"publisher","first-page":"e39433","DOI":"10.1016\/j.heliyon.2024.e39433","volume":"10","author":"Z Azami","year":"2024","unstructured":"Azami Z, Farahmand M, Kavousi M. A new multi-epitope DNA vaccine against Helicobacter Pylori infection in a BALB\/c mouse model. Heliyon. 2024;10(21):e39433.","journal-title":"Heliyon"},{"issue":"8","key":"254_CR12","doi-asserted-by":"publisher","first-page":"e0272582","DOI":"10.1371\/journal.pone.0272582","volume":"17","author":"E Behmard","year":"2022","unstructured":"Behmard E, Abdulabbas HT, Abdalkareem Jasim S, Najafipour S, Ghasemian A, Farjadfar A, Barzegari E, Kouhpayeh A, Abdolmaleki P. Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach. PLoS ONE. 2022;17(8):e0272582.","journal-title":"PLoS ONE"},{"issue":"5","key":"254_CR13","doi-asserted-by":"publisher","first-page":"e0285177","DOI":"10.1371\/journal.pone.0285177","volume":"18","author":"S Mahmoodi","year":"2023","unstructured":"Mahmoodi S, Amirzakaria JZ, Ghasemian A. In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses. PLoS ONE. 2023;18(5):e0285177.","journal-title":"PLoS ONE"},{"key":"254_CR14","doi-asserted-by":"crossref","unstructured":"Ikram A, Zaheer T, Awan FM, Obaid A, Naz A, Hanif R, Paracha RZ, Ali A, Naveed AK, Janjua HA: Exploring NS3\/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches. Scientific Reports. 2018;8(1).","DOI":"10.1038\/s41598-018-34254-5"},{"key":"254_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijbiomac.2020.04.191","volume":"158","author":"M Pritam","year":"2020","unstructured":"Pritam M, Singh G, Swaroop S, Singh AK, Pandey B, Singh SP. A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria. Int J Biol Macromol. 2020;158:159\u201379.","journal-title":"Int J Biol Macromol"},{"key":"254_CR16","first-page":"8","volume":"42","author":"E Behmard","year":"2024","unstructured":"Abdulabbas Hussein T,  Mohammad Ali AN , Farjadfar A, Arabfard M, Najafipour S,  Kouhpayeh SA , Ghasemian A, Behmard E\/.\u00a0Design of a novel multi-epitope vaccine candidate against Chlamydia trachomatis using structural and nonstructural proteins: an immunoinformatics study.\u00a0J Biomol Struct Dyn . 2024;42(8):4356\u201369","journal-title":"J Biomol Struct Dyn"},{"key":"254_CR17","doi-asserted-by":"publisher","first-page":"1203355","DOI":"10.3389\/fmicb.2023.1203355","volume":"14","author":"N Rcheulishvili","year":"2023","unstructured":"Rcheulishvili N, Mao J, Papukashvili D, Feng S, Liu C, Wang X, He Y, Wang PG. Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine. Front Microbiol. 2023;14:1203355.","journal-title":"Front Microbiol"},{"issue":"2","key":"254_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L. Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cell Mol Immunol. 2018;15(2):182\u20134.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"254_CR19","doi-asserted-by":"publisher","first-page":"e0310703","DOI":"10.1371\/journal.pone.0310703","volume":"19","author":"EC Banico","year":"2024","unstructured":"Banico EC, Sira E, Fajardo LE, Dulay ANG, Odchimar NMO, Simbulan AM, Orosco FL. Advancing one health vaccination: In silico design and evaluation of a multi-epitope subunit vaccine against Nipah virus for cross-species immunization using immunoinformatics and molecular modeling. PLoS ONE. 2024;19(9):e0310703.","journal-title":"PLoS ONE"},{"key":"254_CR20","doi-asserted-by":"crossref","unstructured":"Thema N, Tshilwane SI, Pretorius A, Son L, Smith RM, Steyn HC, Liebenberg J, van Kleef M: Identification and characterisation of conserved epitopes of E. ruminantium that activate Th1 CD4(+) T cells: Towards the development of a multi-epitope vaccine. Mol Immunol. 2019;107:106\u201314.","DOI":"10.1016\/j.molimm.2018.12.012"},{"issue":"50","key":"254_CR21","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1021\/acs.biochem.7b00902","volume":"56","author":"M van Rosmalen","year":"2017","unstructured":"van Rosmalen M, Krom M, Merkx M. Tuning the Flexibility of Glycine-Serine Linkers To Allow Rational Design of Multidomain Proteins. Biochemistry. 2017;56(50):6565\u201374.","journal-title":"Biochemistry"},{"issue":"1","key":"254_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12896-024-00873-2","volume":"24","author":"FQJ Al-Zayadi","year":"2024","unstructured":"Al-Zayadi FQJ, Shakir AS, Kareem AS, Ghasemian A, Behmard E. Design of a novel multi-epitope vaccine against Marburg virus using immunoinformatics studies. BMC Biotechnol. 2024;24(1):45.","journal-title":"BMC Biotechnol"},{"issue":"7","key":"254_CR23","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s00436-018-5915-6","volume":"117","author":"N Mortazavidehkordi","year":"2018","unstructured":"Mortazavidehkordi N, Fallah A, Abdollahi A, Kia V, Khanahmad H, Najafabadi ZG, Hashemi N, Estiri B, Roudbari Z, Najafi A, et al. A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB\/C. Parasitol Res. 2018;117(7):2265\u201373.","journal-title":"Parasitol Res"},{"key":"254_CR24","doi-asserted-by":"publisher","first-page":"105423","DOI":"10.1016\/j.ejps.2020.105423","volume":"152","author":"M Rabienia","year":"2020","unstructured":"Rabienia M, Roudbari Z, Ghanbariasad A, Abdollahi A, Mohammadi E, Mortazavidehkordi N, Farjadfar A. Exploring membrane proteins of Leishmania major to design a new multi-epitope vaccine using immunoinformatics approach. Eur J Pharm Sci. 2020;152:105423.","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"254_CR25","doi-asserted-by":"publisher","first-page":"7031492","DOI":"10.1155\/2021\/7031492","volume":"2021","author":"A Fallah","year":"2021","unstructured":"Fallah A, Alipour M, Jamali Z, Farjadfar A, Roshangar L, Partovi Nasr M, Hashemi M, Aghazadeh M. Overexpression Effects of miR-424 and BMP2 on the Osteogenesis of Wharton\u2019s Jelly-Derived Stem Cells. Biomed Res Int. 2021;2021(8):7031492.","journal-title":"Biomed Res Int."},{"issue":"4","key":"254_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2009.22","volume":"4","author":"RH Kutner","year":"2009","unstructured":"Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc. 2009;4(4):495\u2013505.","journal-title":"Nat Protoc"},{"key":"254_CR27","doi-asserted-by":"publisher","first-page":"e38970","DOI":"10.7554\/eLife.38970","volume":"7","author":"WF Shen","year":"2018","unstructured":"Shen WF, Galula JU, Liu JH, Liao MY, Huang CH, Wang YC, Wu HC, Liang JJ, Lin YL, Whitney MT, et al. Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody. Elife. 2018;7:e38970.","journal-title":"Elife."},{"key":"254_CR28","doi-asserted-by":"crossref","unstructured":"Mortazavi Dehkordi N, Ghaffarifar F, Mohammad Hassan Z, Esavand Heydari F: In Vitro and In Vivo Studies of Antileishmanial Effect of Artemether on Leishmania infantum. Jundishapur Journal of Microbiology. 2013;6(5).","DOI":"10.5812\/jjm.6379"},{"issue":"4","key":"254_CR29","doi-asserted-by":"publisher","first-page":"103468","DOI":"10.1016\/j.xpro.2024.103468","volume":"5","author":"LU Teufel","year":"2024","unstructured":"Teufel LU, Dos Santos JC. Protocol to culture Leishmania protozoans for lipophosphoglycan extraction and purification. STAR Protoc. 2024;5(4):103468.","journal-title":"STAR Protoc"},{"key":"254_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fimmu.2020.00204","volume":"11","author":"CB Palatnik-de-Sousa","year":"2020","unstructured":"Palatnik-de-Sousa CB, Nico D. The Delay in the Licensing of Protozoal Vaccines: A Comparative History. Front Immunol. 2020;11:204.","journal-title":"Front Immunol"},{"issue":"11","key":"254_CR31","doi-asserted-by":"publisher","first-page":"e12729","DOI":"10.1111\/pim.12729","volume":"42","author":"P Misra","year":"2020","unstructured":"Misra P, Tandon R, Basak T, Sengupta S, Dube A. Purified Splenic amastigotes of Leishmania donovani-Immunoproteomic approach for exploring Th1 stimulatory polyproteins. Parasite Immunol. 2020;42(11):e12729.","journal-title":"Parasite Immunol"},{"key":"254_CR32","doi-asserted-by":"crossref","unstructured":"Madhubala BSaR: Leishmaniasis: Current Status of Vaccine Development. Current Molecular Medicine 2004;4(6):667-79","DOI":"10.2174\/1566524043360203"},{"key":"254_CR33","doi-asserted-by":"crossref","unstructured":"Bazhan SI, Antonets DV, Karpenko LI, Oreshkova SF, Kaplina ON, Starostina EV, Dudko SG, Fedotova SA, Ilyichev AA: In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice. Vaccines (Basel). 2019;7(2).","DOI":"10.3390\/vaccines7020034"},{"issue":"12","key":"254_CR34","first-page":"1493","volume":"22","author":"G Salehi-Sangani","year":"2019","unstructured":"Salehi-Sangani G, Mohebali M, Jajarmi V, Khamesipour A, Bandehpour M, Mahmoudi M, Zahedi-Zavaram H. Immunization against Leishmania major infection in BALB\/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens. Iran J Basic Med Sci. 2019;22(12):1493\u2013501.","journal-title":"Iran J Basic Med Sci"},{"key":"254_CR35","doi-asserted-by":"crossref","unstructured":"Gharaei A, Rahdar M, Jorjani O, Saberi S, Beiromvand M, Feiz-Haddad MH: Evaluation of the immunogenicity of a DNA vaccine for Leishmania major based on the Leishmania-activated C kinase antigen using calcium phosphate and chitosan adjuvants. Trans R Soc Trop Med Hyg.  2025;7;119(3):266\u201373","DOI":"10.1093\/trstmh\/trae126"},{"key":"254_CR36","doi-asserted-by":"crossref","unstructured":"Lopes Valentim Di Paschoale Ostolin T, Rodrigues Gusm\u00e3o M, Augusto Siqueira Mathias F, Mirelle de Oliveira Cardoso J, Mendes Roatt B, Dian de Oliveira Aguiar-Soares R, Concei\u00e7\u00e3o Ruiz J, de Melo Resende D, Cristiane Fortes de Brito R, Barbosa Reis A: A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis. Cell Immunol. 2022;380:104592.","DOI":"10.1016\/j.cellimm.2022.104592"},{"key":"254_CR37","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3389\/fimmu.2020.01725","volume":"11","author":"N Keshavarzian","year":"2020","unstructured":"Keshavarzian N, Noroozbeygi M. Haji Molla Hoseini M, Yeganeh F: Evaluation of Leishmanization Using Iranian Lizard Leishmania Mixed With CpG-ODN as a Candidate Vaccine Against Experimental Murine Leishmaniasis. Front Immunol. 2020;11:1725.","journal-title":"Front Immunol"},{"key":"254_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exppara.2019.05.004","volume":"203","author":"S Reza","year":"2019","unstructured":"Reza S, Hasan NA, Maryam NF, Fahimeh B, Ghahremani A, GholamReza H, Amin GM. Cytokine profile and nitric oxide levels in macrophages exposed to Leishmania infantum FML. Exp Parasitol. 2019;203:1\u20137.","journal-title":"Exp Parasitol"},{"issue":"10","key":"254_CR39","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1128\/IAI.00184-15","volume":"83","author":"P Bhattacharya","year":"2015","unstructured":"Bhattacharya P, Dey R, Dagur PK, Kruhlak M, Ismail N, Debrabant A, Joshi AB, Akue A, Kukuruga M, Takeda K, et al. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Infect Immun. 2015;83(10):3800\u201315.","journal-title":"Infect Immun"},{"issue":"9","key":"254_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/pathogens13090812","volume":"13","author":"A Ayala","year":"2024","unstructured":"Ayala A, Llanes A, Lleonart R, Restrepo CM. Advances in Leishmania Vaccines: Current Development and Future Prospects. Pathogens. 2024;13(9):812.","journal-title":"Pathogens"},{"issue":"40","key":"254_CR41","doi-asserted-by":"publisher","first-page":"17292","DOI":"10.1073\/pnas.1004879107","volume":"107","author":"E Mohr","year":"2010","unstructured":"Mohr E, Cunningham AF, Toellner KM, Bobat S, Coughlan RE, Bird RA, MacLennan IC, Serre K. IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc Natl Acad Sci U S A. 2010;107(40):17292\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"254_CR42","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1016\/j.vaccine.2008.04.046","volume":"26","author":"H Cong","year":"2008","unstructured":"Cong H, Gu QM, Yin HE, Wang JW, Zhao QL, Zhou HY, Li Y, Zhang JQ. Multi-epitope DNA vaccine linked to the A2\/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine. 2008;26(31):3913\u201321.","journal-title":"Vaccine"},{"issue":"9","key":"254_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott P, Novais FO. Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol. 2016;16(9):581\u201392.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"254_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1700674","volume":"200","author":"A Banerjee","year":"2018","unstructured":"Banerjee A, Bhattacharya P, Dagur PK, Karmakar S, Ismail N, Joshi AB, Akue AD, KuKuruga M, McCoy JP Jr, Dey R, et al. Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model. J Immunol. 2018;200(1):163\u201376.","journal-title":"J Immunol"},{"issue":"1","key":"254_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00430-019-00640-7","volume":"209","author":"B Vakili","year":"2020","unstructured":"Vakili B, Nezafat N, Zare B, Erfani N, Akbari M, Ghasemi Y, Rahbar MR, Hatam GR. A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice. Med Microbiol Immunol. 2020;209(1):69\u201379.","journal-title":"Med Microbiol Immunol"},{"key":"254_CR46","doi-asserted-by":"crossref","unstructured":"Yoon KW, Chu KB, Eom GD, Mao J, Moon EK, Kim SS, Quan FS: CpG-adjuvanted virus-like particle vaccine induces protective immunity against Leishmania donovani infection. J Infect Dis. 2024;","DOI":"10.1093\/infdis\/jiae526"},{"issue":"9","key":"254_CR47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3855\/jidc.14472","volume":"15","author":"T Aunguldee","year":"2021","unstructured":"Aunguldee T, Gerdprasert O, Tangteerawatana P, Jariyapongskul A, Leelayoova S, Wongsatayanon BT. Immunogenicity and potential protection of DNA vaccine of Leishmania martiniquensis against Leishmania infection in mice. J Infect Dev Ctries. 2021;15(9):1328\u201338.","journal-title":"J Infect Dev Ctries"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-025-00254-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-025-00254-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-025-00254-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T22:02:43Z","timestamp":1751320963000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-025-00254-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1186\/s40794-025-00254-3","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed on twenty-four female inbred BALB\/c mice, based on the specific National Ethical Guidelines for Biomedical Research issued by the Research and Technology Deputy of Ministry of Health and Medicinal Education (MOHME) of Iran. The ethical code of the work includes IR.FUMS.REC.1396.319. The study is reported in accordance with ARRIVE guidelines ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have the consent to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}